Weber W, Kewitz G, Rost K L, Looby M, Nitz M, Harnisch L
Department of Clinical Pharmacology, Free University of Berlin, Klinikum Steglitz, Germany.
Eur J Clin Pharmacol. 1993;44 Suppl 1:S23-5. doi: 10.1007/BF01428387.
A population kinetic analysis was carried out on sparse plasma gentamicin (GE) concentration data from 469 neonates obtained as part of a routine therapeutic drug monitoring (TDM) programme in the hospital neonatology unit. The best predictors of the kinetic parameters of the monoexponential model, volume of distribution (Vd) and clearance (CL), were the weight (WT) and gestational age (GA). Vd of the neonates was only related to WT, whereas the half-life was only related to the GA. The clinical implications of the findings are that the initial dose per WT administered to premature infants should be larger than that for term infants, because of a larger Vd per unit WT, and the intervals between maintenance doses should extended due to the prolonged half-life. Apart from these general guidelines, specific dose recommendations are also given.
对医院新生儿科常规治疗药物监测(TDM)项目中获取的469例新生儿稀疏血浆庆大霉素(GE)浓度数据进行了群体动力学分析。单指数模型的动力学参数,即分布容积(Vd)和清除率(CL)的最佳预测因子是体重(WT)和胎龄(GA)。新生儿的Vd仅与WT有关,而半衰期仅与GA有关。这些发现的临床意义在于,由于单位体重的Vd较大,给予早产儿每千克体重的初始剂量应大于足月儿,并且由于半衰期延长,维持剂量之间的间隔应延长。除了这些一般指南外,还给出了具体的剂量建议。